» Authors » April Wong

April Wong

Explore the profile of April Wong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dempsey K, Mathieu E, Brennan M, Snook K, Hoffman J, Campbell I, et al.
Breast . 2023 Aug; 71:122-131. PMID: 37573653
Background: Breast reconstruction (BR) improves women's health-related quality of life (HRQOL) following mastectomy for breast cancer, yet factors contributing to improved HRQOL remain unclear. This study aimed to explore the...
2.
Tripathi M, Wong A, Solomon V, Yassine H
Endocr Pract . 2021 Jan; 27(1):71-76. PMID: 33475504
Objective: To estimate the prevalence of probable familial chylomicronemia syndrome (FCS) in a major Southern California Academic Center as well as to provide a systematic review of past FCS studies...
3.
Lau G, Benhamou Y, Chen G, Li J, Shao Q, Ji D, et al.
Lancet Gastroenterol Hepatol . 2016 Dec; 1(2):97-104. PMID: 27917405
Background: To shorten the course of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, we examined the antiviral efficacy and safety of 3 weeks of response-guided therapy with...
4.
Wang C, Ji D, Chen J, Shao Q, Li B, Liu J, et al.
Clin Gastroenterol Hepatol . 2016 Jul; 15(1):132-136. PMID: 27392759
Hepatitis due to reactivation of hepatitis B virus (HBV) has been reported in patients treated with direct-acting antiviral (DAA) agents for chronic hepatitis C virus infection. We performed an observational...
5.
Chen G, Wei L, Chen J, Duan Z, Dou X, Xie Q, et al.
PLoS One . 2016 Jun; 11(6):e0155934. PMID: 27276081
Background: Little is known on the cost-effectiveness of novel regimens for hepatitis C virus (HCV) compared with standard-of-care with pegylated interferon (pegIFN) and ribavirin (RBV) therapy in developing countries. We...
6.
Flitcroft K, Brennan M, Costa D, Wong A, Snook K, Spillane A
Psychooncology . 2016 Feb; 25(12):1463-1469. PMID: 26880525
Objective: Women with locally advanced breast cancer face many conflicting issues affecting their choice of immediate versus delayed versus no breast reconstruction (BR). This single-centre pilot study assessed high-risk women's...
7.
Brennan M, Spillane A, Flitcroft K, Snook K, Wong A
ANZ J Surg . 2014 Oct; 84(9):604-5. PMID: 25302350
No abstract available.
8.
Wong A, Snook K, Brennan M, Flitcroft K, Tucker M, Hiercz D, et al.
ANZ J Surg . 2014 Jan; 84(1-2):31-6. PMID: 24450788
Background: Breast reconstruction (BR) following mastectomy for breast cancer is safe and has high rates of patient satisfaction, yet only around 12% of Australian women undergo BR. This study presents...
9.
Talamas F, Ao-Ieong G, Brameld K, Chin E, De Vicente J, Dunn J, et al.
J Med Chem . 2013 Mar; 56(7):3115-9. PMID: 23509929
The use of fragments with low binding affinity for their targets as starting points has received much attention recently. Screening of fragment libraries has been the most common method to...
10.
Wong A, Spillane A
ANZ J Surg . 2012 Sep; 84(1-2):37-41. PMID: 23013050
Background: Patent Blue V dye (PBVD) can cause severe anaphylaxis. For sentinel node biopsy (SNB) in breast cancer patients, controversy exists as to the utility of PBVD in addition to...